Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3 - PubMed (original) (raw)
. 2011 Oct;92(Pt 10):2394-2398.
doi: 10.1099/vir.0.034322-0. Epub 2011 Jun 22.
Affiliations
- PMID: 21697347
- DOI: 10.1099/vir.0.034322-0
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3
M Mutocheluh et al. J Gen Virol. 2011 Oct.
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) encodes four viral interferon regulatory factors (vIRF-1-4). We investigated the mechanism and consequences of vIRF-2-mediated inhibition of interferon-response element signalling following type I interferon (IFN) induction. Western blot and electrophoretic mobility-shift assays identified the interferon-stimulated gene factor-3 (ISGF-3) components STAT1 and IRF-9 as the proximal targets of vIRF-2 activity. The biological significance of vIRF-2 inhibition of ISGF-3 was demonstrated by vIRF-2-mediated rescue of the replication of the IFN-sensitive virus encephalomyocarditis virus. This study provides both a mechanism and evidence for KSHV vIRF-2-mediated suppression of the consequences of type 1 IFN-induced signalling.
Publication types
MeSH terms
Substances
Grants and funding
- G0400408/MRC_/Medical Research Council/United Kingdom
- G0401584/MRC_/Medical Research Council/United Kingdom
- G0800154/MRC_/Medical Research Council/United Kingdom
- CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous